BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 37277922)

  • 41. Thrombotic events with or without thrombocytopenia in recipients of adenovirus-based COVID-19 vaccines.
    Cari L; Naghavi Alhosseini M; Bergamo A; Pacor S; Pierno S; Sava G; Nocentini G
    Front Cardiovasc Med; 2022; 9():967926. PubMed ID: 36247442
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ad26.COV2.S Vaccine-Induced Thrombocytopenia Leading to Dural Sinus Thrombosis and Intracranial Hemorrhage Requiring Hemicraniectomy: A Case Report and Systematic Review.
    Daly S; Nguyen AV; Soto JM; Vance AZ
    Cureus; 2022 Aug; 14(8):e28083. PubMed ID: 36127984
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Understanding vaccine-induced thrombotic thrombocytopenia (VITT).
    Dix C; McFadyen J; Huang A; Chunilal S; Chen V; Tran H
    Intern Med J; 2022 May; 52(5):717-723. PubMed ID: 35446471
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Post-SARS-CoV-2-vaccination cerebral venous sinus thrombosis: an analysis of cases notified to the European Medicines Agency.
    Krzywicka K; Heldner MR; Sánchez van Kammen M; van Haaps T; Hiltunen S; Silvis SM; Levi M; Kremer Hovinga JA; Jood K; Lindgren E; Tatlisumak T; Putaala J; Aguiar de Sousa D; Middeldorp S; Arnold M; Coutinho JM; Ferro JM
    Eur J Neurol; 2021 Nov; 28(11):3656-3662. PubMed ID: 34293217
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of anti-PF4 versus anti-PF4/heparin reactivity using fluid-phase enzyme immunoassay for 4 anti-PF4 disorders: classic heparin-induced thrombocytopenia (HIT), autoimmune HIT, vaccine-induced immune thrombotic thrombocytopenia, and spontaneous HIT.
    Warkentin TE; Arnold DM; Sheppard JI; Moore JC; Kelton JG; Nazy I
    J Thromb Haemost; 2023 Aug; 21(8):2268-2276. PubMed ID: 37182698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of anti-platelet factor 4 antibodies and platelet activation tests in patients with vaccine-induced immune thrombotic thrombocytopenia: Brief report on a comparison of the laboratory diagnosis and literature review.
    Hsiao PJ; Wu KL; Chen YC; Chen YL; Wang RL; Wu KA; Chan JS; Chiu CC; Huang LY; Shyu HY; Kao YH; Chuu CP
    Clin Chim Acta; 2022 Apr; 529():42-45. PubMed ID: 35167842
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Cerebral Venous Sinus Thrombosis Following COVID-19 Vaccination: A Systematic Review.
    Jaiswal V; Nepal G; Dijamco P; Ishak A; Dagar M; Sarfraz Z; Shama N; Sarfraz A; Lnu K; Mitra S; Agarwala P; Naz S; Song D; Jaiswal A
    J Prim Care Community Health; 2022; 13():21501319221074450. PubMed ID: 35142234
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High Incidence and Unique Features of Cerebral Venous Sinus Thrombosis in Hospitalized Patients With COVID-19 Infection.
    McCullough-Hicks ME; Halterman DJ; Anderson D; Cohen K; Lakshminarayan K
    Stroke; 2022 Sep; 53(9):e407-e410. PubMed ID: 35920155
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Post COVID-19 Vaccine Related Cerebral Venous Sinus Thrombosis and Thrombocytopenia.
    Butler-Manuel W; Rana UI; Zafar M; Gadi A; Kiani A
    Cureus; 2022 Jan; 14(1):e20932. PubMed ID: 35004085
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Vaccine-induced immune thrombotic thrombocytopenia post dose 2 ChAdOx1 nCoV19 vaccination: Less severe but remains a problem.
    Clarke L; Brighton T; Chunilal SD; Lee CSM; Passam F; Curnow J; Chen VM; Tran HA
    Vaccine; 2023 May; 41(20):3285-3291. PubMed ID: 37085453
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical significance of hepatosplenic thrombosis in vaccine-induced immune thrombotic thrombocytopenia after ChAdOx1 nCoV-19 vaccination.
    Hwang J; Han YJ; Yon DK; Lee SW; Kim BK; Lee SB; Lee MH; Park SH; Koyanagi A; Jacob L; Tizaoui K; Kim SU; Shin JI; Smith L
    Int J Infect Dis; 2022 Mar; 116():114-121. PubMed ID: 34958931
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebral venous sinus thrombosis after ChAdOx1 vaccination: the first case of definite thrombosis with thrombocytopenia syndrome from India.
    Maramattom BV; Moidu FM; Varikkottil S; Syed AA
    BMJ Case Rep; 2021 Oct; 14(10):. PubMed ID: 34706921
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Immunohistologic Features of Cerebral Venous Thrombosis Due to Vaccine-Induced Immune Thrombotic Thrombocytopenia.
    Geeraerts T; Guilbeau-Frugier C; Garcia C; Memier V; Raposo N; Bonneville F; Gales C; Darcourt J; Voisin S; Ribes A; Piel-Julian M; Bounes F; Albucher JF; Roux FE; Izopet J; Telmon N; Olivot JM; Sié P; Bauer J; Payrastre B; Liblau RS
    Neurol Neuroimmunol Neuroinflamm; 2023 Jul; 10(4):. PubMed ID: 37236806
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mechanisms of Immunothrombosis in Vaccine-Induced Thrombotic Thrombocytopenia (VITT) Compared to Natural SARS-CoV-2 Infection.
    McGonagle D; De Marco G; Bridgewood C
    J Autoimmun; 2021 Jul; 121():102662. PubMed ID: 34051613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vaccine-induced immune thrombotic thrombocytopenia post COVID-19 booster vaccination in Brazil: a case series.
    Mendes-de-Almeida DP; ; Mouta Nunes de Oliveira P; Bertollo Gomes Porto V; Saraiva Pedro R; Takey PRG; Lignani LK; Vitiello Teixeira G; Pereira TDS; Abreu DL; Xavier JR; Castro TDM; Melo de Amorim Filho L; Sousa Maia ML
    Res Pract Thromb Haemost; 2023 Nov; 7(8):102243. PubMed ID: 38193064
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vaccine-induced immune thrombotic thrombocytopenia (VITT): Update on diagnosis and management considering different resources.
    Greinacher A; Langer F; Makris M; Pai M; Pavord S; Tran H; Warkentin TE
    J Thromb Haemost; 2022 Jan; 20(1):149-156. PubMed ID: 34693641
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Treatment of ChAdOx1 nCoV-19 Vaccine-Induced Immune Thrombotic Thrombocytopenia Related Acute Ischemic Stroke.
    Kenda J; Lovrič D; Škerget M; Milivojević N
    J Stroke Cerebrovasc Dis; 2021 Nov; 30(11):106072. PubMed ID: 34461442
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cerebral Venous Sinus Thrombosis is not Significantly Linked to COVID-19 Vaccines or Non-COVID Vaccines in a Large Multi-State Health System.
    Pawlowski C; Rincón-Hekking J; Awasthi S; Pandey V; Lenehan P; Venkatakrishnan AJ; Bade S; O'Horo JC; Virk A; Swift MD; Williams AW; Gores GJ; Badley AD; Halamka J; Soundararajan V
    J Stroke Cerebrovasc Dis; 2021 Oct; 30(10):105923. PubMed ID: 34627592
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cerebral Venous Thrombosis Developing after COVID-19 Vaccination: VITT, VATT, TTS, and More.
    Lippi G; Favaloro EJ
    Semin Thromb Hemost; 2022 Feb; 48(1):8-14. PubMed ID: 34695859
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Cerebral venous sinus thrombosis after COVID-19 vaccination : Neurological and radiological management].
    Walter U; Volmer E; Wittstock M; Storch A; Weber MA; Großmann A
    Radiologe; 2021 Oct; 61(10):923-932. PubMed ID: 34327553
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.